Net profit of Emcure Pharmaceuticals rose 35.50% to Rs 153.72 crore in the quarter ended December 2024 as against Rs 113.45 crore during the previous quarter ended December 2023. Sales rose 17.69% to Rs 1962.63 crore in the quarter ended December 2024 as against Rs 1667.64 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 1962.63 | 1667.64 | 18 |
OPM % | 18.43 | 17.61 | - |
PBDT | 326.73 | 262.01 | 25 |
PBT | 229.92 | 177.62 | 29 |
NP | 153.72 | 113.45 | 35 |